101 related articles for article (PubMed ID: 19471103)
21. Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis.
Laudes M; Christodoulides C; Sewter C; Rochford JJ; Considine RV; Sethi JK; Vidal-Puig A; O'Rahilly S
J Biol Chem; 2004 Mar; 279(12):11711-8. PubMed ID: 14701838
[TBL] [Abstract][Full Text] [Related]
22. eEF1A mediates the nuclear export of SNAG-containing proteins via the Exportin5-aminoacyl-tRNA complex.
Mingot JM; Vega S; Cano A; Portillo F; Nieto MA
Cell Rep; 2013 Nov; 5(3):727-37. PubMed ID: 24209753
[TBL] [Abstract][Full Text] [Related]
23. KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A.
Jeon BN; Kim MK; Choi WI; Koh DI; Hong SY; Kim KS; Kim M; Yun CO; Yoon J; Choi KY; Lee KR; Nephew KP; Hur MW
Cancer Res; 2012 Mar; 72(5):1137-48. PubMed ID: 22253232
[TBL] [Abstract][Full Text] [Related]
24. FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles.
Pendergrast PS; Wang C; Hernandez N; Huang S
Mol Biol Cell; 2002 Mar; 13(3):915-29. PubMed ID: 11907272
[TBL] [Abstract][Full Text] [Related]
25. TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1.
Hsu SI; Yang CM; Sim KG; Hentschel DM; O'Leary E; Bonventre JV
EMBO J; 2001 May; 20(9):2273-85. PubMed ID: 11331592
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
27. Mouse translation elongation factor eEF1A-2 interacts with Prdx-I to protect cells against apoptotic death induced by oxidative stress.
Chang R; Wang E
J Cell Biochem; 2007 Feb; 100(2):267-78. PubMed ID: 16888816
[TBL] [Abstract][Full Text] [Related]
28. Structure of the POZ domain of human LRF, a master regulator of oncogenesis.
Schubot FD; Tropea JE; Waugh DS
Biochem Biophys Res Commun; 2006 Dec; 351(1):1-6. PubMed ID: 17052694
[TBL] [Abstract][Full Text] [Related]
29. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
30. Progesterone-dependent deoxyribonucleic acid looping between RUSH/SMARCA3 and Egr-1 mediates repression by c-Rel.
Hewetson A; Chilton BS
Mol Endocrinol; 2008 Apr; 22(4):813-22. PubMed ID: 18174357
[TBL] [Abstract][Full Text] [Related]
31. Binding of the eukaryotic translation elongation factor 1A with the 5'UTR of HIV-1 genomic RNA is important for reverse transcription.
Li D; Wei T; Jin H; Rose A; Wang R; Lin MH; Spann K; Harrich D
Virol J; 2015 Aug; 12():118. PubMed ID: 26242867
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
33. The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding.
Lee KM; Choi WI; Koh DI; Kim YJ; Jeon BN; Yoon JH; Lee CE; Kim SH; Oh J; Hur MW
Oncogene; 2012 Mar; 31(11):1442-58. PubMed ID: 21804610
[TBL] [Abstract][Full Text] [Related]
34. A non-catalytic N-terminal domain negatively influences the nucleotide exchange activity of translation elongation factor 1Bα.
Trosiuk TV; Shalak VF; Szczepanowski RH; Negrutskii BS; El'skaya AV
FEBS J; 2016 Feb; 283(3):484-97. PubMed ID: 26587907
[TBL] [Abstract][Full Text] [Related]
35. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
[TBL] [Abstract][Full Text] [Related]
36. Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.
Lamberti A; Sanges C; Chambery A; Migliaccio N; Rosso F; Di Maro A; Papale F; Marra M; Parente A; Caraglia M; Abbruzzese A; Arcari P
Biochimie; 2011 Oct; 93(10):1738-46. PubMed ID: 21689717
[TBL] [Abstract][Full Text] [Related]
37. Flexible DNA binding of the BTB/POZ-domain protein FBI-1.
Pessler F; Hernandez N
J Biol Chem; 2003 Aug; 278(31):29327-35. PubMed ID: 12750370
[TBL] [Abstract][Full Text] [Related]
38. Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells.
Sanges C; Scheuermann C; Zahedi RP; Sickmann A; Lamberti A; Migliaccio N; Baljuls A; Marra M; Zappavigna S; Reinders J; Rapp U; Abbruzzese A; Caraglia M; Arcari P
Cell Death Dis; 2012 Mar; 3(3):e276. PubMed ID: 22378069
[TBL] [Abstract][Full Text] [Related]
39. Characterization of elongation factor-1A (eEF1A-1) and eEF1A-2/S1 protein expression in normal and wasted mice.
Khalyfa A; Bourbeau D; Chen E; Petroulakis E; Pan J; Xu S; Wang E
J Biol Chem; 2001 Jun; 276(25):22915-22. PubMed ID: 11294870
[TBL] [Abstract][Full Text] [Related]
40. New insights on the interaction between the isoforms 1 and 2 of human translation elongation factor 1A.
Migliaccio N; Ruggiero I; Martucci NM; Sanges C; Arbucci S; Tatè R; Rippa E; Arcari P; Lamberti A
Biochimie; 2015 Nov; 118():1-7. PubMed ID: 26212729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
